A Cleveland Clinic podcast exploring heart, vascular and thoracic topics of interest to healthcare providers: medical and surgical treatments, diagnostic testing, medical conditions, and research, technology and practice issues.
Cleveland Clinic Heart & Vascular Institute
There are two main goals to focus on while caring for patients with peripheral arterial disease (PAD). Teresa Wu, MD, from the Section of Vascular Medicine at Cleveland Clinic talks about these two goals and insights into PAD management.
Michael Zhen-Yu Tong, MD, provides an update on Cleveland Clinic Heart, Vascular & Thoracic Institute's Heart Failure & Transplantation Program.
Heart transplantation is a chance at life for patients. Natalie Salvatore, RN, interviews Eileen Hsich, MD, Medical Director for the Heart Transplant Program at Cleveland Clinic, about caring for patients who might require heart transplantation, next steps if they are not a candidate and her biggest piece of advice.
Faisal Bakaeen, MD, provides an update on Cleveland Clinic Heart, Vascular and Thoracic Institute Coronary Artery Disease Center's 2022 results.
In 2020, same day discharge and next day discharge accounted for 22.1 percent (n = 114 of 516) and 63.8 percent (n = 329 of 516) of outpatient TF-TAVR. Samir Kapadia, MD, Chairman of Cardiology, and Amar Krishnaswamy, MD, Head of Interventional Cardiology, discuss discharge planning considerations for patients having TAVR and the benefit of same day discharge if appropriate.
Eric Roselli, MD, provides an update on Cleveland Clinic Heart, Vascular and Thoracic Institute Aorta Center's 2022 results.
A Cleveland Clinic-led trial found that testosterone-replacement therapy did not result in a higher incidence of major adverse cardiac events in middle-aged and older men with hypogonadism (also known as low testosterone) who also had preexisting or a high risk of cardiovascular disease. However, researchers still urge caution when considering testosterone therapy. Dr. Steve Nissen discusses the results of the TRAVERSE trial.
Daniel Burns, MD, provides an update on 2022's valve results. Learn more: https://my.clevelandclinic.org/departments/heart/depts/valve-center
Thomas Callahan, MD, electrophysiologist and Co-Director, Lead Extraction Program, discusses the incidence of sudden cardiac death in athletic populations. Dr. Callahan reviews how often SCD occurs in athletes, the etiology and survival, drawing from studies in the US, Canada, the United Kingdom and France.
Aortopathies can have implications for patients who are athletes. Sagar Kalahasti, MD, Director of the Marfan Syndrome and Connective Tissue Disorder Clinic and member of the Aorta Center, discusses etiologies and evaluation of aortopathies in the athletic heart.
Cleveland Clinic is dedicated to providing a world-class experience to students, residents, and fellows. Frank Caputo, MD, Program Director of the Vascular Surgery Training Programs and staff vascular surgeon in the Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute, highlights benefits of the vascular surgery program, including tools, opportunities and leadership roles.
Life after a cardiac event can be difficult for patients to adjust to, especially for athletes. The decision to return to play is important and must be made by weighing the risks and benefits for each person. Michael Emery, MD, Co-Director of the Sports Cardiology Center, talks about considerations for return to play and the shared decision-making process.
Ayman Hussein, MD, discusses single shot ablation using radiofrequency.
Pre-participation evaluation is a useful tool for evaluating athletes for cardiovascular risks. Tamanna Singh, MD, provides an overview of different modalities to evaluate a patient with an athletic heart.
An overview from session moderator Leben Tefera, MD, case presented by Muhammad Khalid, MD, Scott Cameron, MD, PhD, provides background on PERTs and outcomes, and Karen Hurley, PhD, discusses psychological care and follow for Acute PE performed.
"Although statins play a pivotal role in the prevention of atherosclerotic cardiovascular disease, many patients fail to achieve recommended lipid levels due to statin-associated muscle symptoms." The CLEAR Outcomes trial evaluated the effect of bempedoic acid on cardiovascular events in patients with statin intolerance. Steve Nissen, MD, Chief Academic Officer of Cleveland Clinic's Heart, Vascular and Thoracic Institute, provides a summary of this trial.
John Rickard, MD, provides an overview of integrated care for the HF device patient, the CRT-CHF Clinic.
The diagnosis and treatment of lymphedema and lipedema are complex. Douglas Joseph, DO, and John Bartholomew, MD, discuss differentiating factors for diagnosis and management for both lymphedema and lipedema. Interested in referring a patient? We are happy to help. Call toll-free 800.223.2273, ext. 49162.
Francis Caputo, MD, provides an overview of the session, Xiaoying Lou, MD, presents a case, Eric E. Roselli, MD, discusses biomechanics of the aorta, and Christina Rigelsky, MS, highlights the importance of screening family members for possible heritable thoracic aortic disease.
PAD affects nearly 20 million Americans. An estimated 200,000 people, disproportionately from minorities communities, suffer avoidable amputations every year. Dr. Scott Cameron, Section Head for Vascular Medicine at Cleveland Clinic, hosts a 2-part, multidisciplinary panel discussion. Drs. Luke Laffin, Teresa Wu, Aravinda Nanjundappa and Jon Quatromoni share their insights as experts in their fields. Part 2 highlights medications, interventions and the benefits of these various specialties collaborating to ensure patients receive the best possible care.
PAD affects nearly 20 million Americans. An estimated 200,000 people, disproportionately from minorities communities, suffer avoidable amputations every year. Dr. Scott Cameron, Section Head for Vascular Medicine at Cleveland Clinic, hosts a 2-part, multidisciplinary panel discussion. Drs. Luke Laffin, Teresa Wu, Aravinda Nanjundappa, and Jon Quatromoni share their insights as experts in their fields. Part 1 highlights screening and testing, supervised exercise therapy, and wounds.
Allan Klein, MD, provides an overview and moderates a Tall RoundsĀ® session on Constrictive Pericarditis: Tales from the Thickened Pericardial Sac.
Amit Goyal, MD presents a case on the spectrum of constriction, Wael Jaber, MD, discusses stable ischemic heart disease guidelines, and Faisal Bakaeen, MD, highlights when and how CABG should be performed.
Patients with allergies to certain metals and compounds can make safely treating them challenging. Dr. Tom Callahan and Dr. Bruce Wilkoff speak with Dr. John Anthony, Dermatology, and Dr. James Taylor, Clinical Professor of Dermatology, regarding treatment plans for patients with allergies to compounds in implantable cardiac devices.
Patients with allergies to certain metals and compounds can make safely treating them challenging. Dr. Tom Callahan and Dr. Bruce Wilkoff speak with Dr. John Anthony, Dermatology, and Dr. James Taylor, Clinical Professor of Dermatology, regarding diagnosis and testing for patients with suspected allergies to compounds in implantable cardiac devices.
Bruce Wilkoff, MD, discusses the clinical and economic impact of CIED infection.
Spontaneous pneumothorax is an abnormal condition of the lung characterized by the collection of gas in the pleural space. Natalie Salvatore, RN, speaks with Alex Bribriesco, MD, to provide an overview of diagnosis and management of patients with spontaneous pneumothorax. Looking to refer a patient? Call the referring Physician Hotline 24/7: 855.REFER.123 (855.733.3712)
Walid Saliba, MD provides an overview of the PINNACLE and OPTION Trials.
It can be challenging to manage lymphedema. It is a chronic disease that requires patients' adherence to the treatment plan. Dr. Douglas Joseph, one of the medical directors of the multi-disciplinary lymphedema clinic, provides an overview of lymphedema management.
Paul Cremer, MD, provides an overview of imaging modalities for detection and assessment, Andrew Bauer, MD, discusses the intraoperative CTA perspective, and Sagar Kalahasti, MD, highlights postoperative management and considerations.
Sudden cardiac arrest or death can be traumatic for everyone involved. The important thing to focus on is immediate emergency medical attention and resuscitation. Dr. Michael Emery and Dr. Tamanna Singh, Co-Directors of the Sports Cardiology Center, discuss considerations for patients who have experienced sudden cardiac arrest on the field.
Overview of the Phases of Care: Dr. Joanna Ghobrial - Preoperative Phase: Diagnosis, Optimizing Medical Tx, and When to Intervene, Dr. Eric Roselli - Intraoperative Surgical / Interventional Perspective: Open vs Endo vs Hybrid, and Dr. Margaret Fuchs - Postoperative Phase: Lifestyle Recommendations and Providing Lifelong Care and Surveillance.
The Ventricular Arrhythmia Center at Cleveland Clinic utilizes a multidisciplinary approach to managing patients with VT. Oussama Wazni, MD, MBA, speaks with Pasquale Santangeli, MD, PhD, the Director of the Ventricular Arrhythmia Center, about treatment techniques for patients with ventricular arrhythmias.
Milind Desai, MD provides an overview of the preoperative phase: screening, watchful waiting, and moving forward, and Patrick Vargo, MD, discusses the intraoperative surgical perspective: valve options and how much aorta do I resect?
The American Diabetes Associate released their 2023 Standards of Care with updated practice recommendations and guidelines this month. Natalie Salvatore, RN, and Dennis Bruemmer, MD, PhD, discuss the highlights and changes as well as what you need to know to best care for patients with diabetes and heart disease.
Dr. Patrick Collier provides an overview of the multidisciplinary approach to Cleveland Clinic's Cardiovascular Oncology Center.
Familial hypercholesterolemia (FH) is an inherited lipid disorder affecting 1 in 220 individuals resulting in highly elevated low-density lipoprotein levels and risk of premature coronary disease. Dr. Leslie Cho and Dr. Ashish Sarraju discuss some of the nuances of managing patients with FH.
Dr. Scott Cameron discusses the diagnoses of non-atherosclerotic lower extremity arterial disease.
Simple is not so simple anymore. Assessment, diagnosis, and treatment of mitral valve disease is rapidly evolving. A Case Based Approach to Mastering the Mitral Valve: Imaging, Innovation, and Intervention is an educational activity designed to highlight key insights using a case-based approach. Come see Drs. Brian Griffin and Marc Gillinov present alongside other experts in the field of mitral valve.
In the U.S. from March 2020 to June 2021, 147 lung transplants took place for COVID fibrosis or COVID ARDS. In this podcast, Dr. Kenneth McCurry and Dr. Marie Budev, surgical director and medical director, respectively, of the Lung and Heart-Lung Transplant Program at Cleveland Clinic discuss COVID-19, ARDS, fibrosis and the potential role of lung transplantation to treat those patients with advanced disease.
Dr. Amar Krishnaswamy discusses the management of heart failure with functional mitral regurgitation.
Hemodynamic stability is crucial after any operation. Dr. Scott Cameron discusses some of the nuances of medication management for patients who have undergone surgery on their aorta.
Dr. Sudish Murthy discusses thoracic surgery techniques and robotic tracheal resection.
Over the last decade, the tricuspid valve has transformed from being the āforgotten valveā to gaining clinical attention as the one of the next frontiers in structural heart disease. The evolving landscape of structural interventions and multimodality imaging have led to advances in the assessment and management of TR. Dr. Tom Wang discusses considerations for the evaluation and management of TR.
Venu Menon, MD, provides an overview of the preoperative hyperacute phase, and Ran Lee, MD, discusses the postoperative phase in the ICU.
Rishi Puri, MD, PhD discusses future horizons in LV restoration, and Chonyang Albert, MD, provides a case presentation and case follow-up.
Congenital heart defects are the most common type of birth defect and a leading cause of pulmonary valve disease. Patients may not recognize that they are symptomatic. Dr. Joanna Ghobrial outlines the care and management for patients with pulmonary valve disease.
Lung Transplant A-Z: From Referring a Patient to the Impact of COVID-19. Together Dr. Raed Dweik, Chair of the Respiratory Institute, and Dr. Marie Budev, Director of the Lung Transplant Program, tackle the huge subject of lung transplant, covering a range of topics that includes when the right time to refer a patient is and what the contraindications are for transplant. They discuss the Lung Allocation Score, lung transplant survival rate and how long it takes to get a patient ready for transplant. Dr. Budev also talks about new ways in which the donor lung pool is being expanded and the impact of COVID-19 on lung transplant patients.
Pulmonary Hypertension occurs in about 10 percent of patients with congenital heart defects. Dr. Joanna Ghobrial, specializing in adult congenital heart disease, and Dr. Neal Chaisson, specializing in pulmonary hypertension, discuss the benefits of using a multidisciplinary approach to manage patients with both pulmonary hypertension and congenital heart defects.
Dr. Venu Menon and Dr. Edward Soltesz discuss cardiogenic shock and strategic opportunities.
N-3 polyunsaturated fatty acids, also known as omega 3s or fish oil, claim to have a benefit for cardiovascular health. Dr. Steven Nissen and Dr. Luke Laffin discuss the results of recent trials focusing on the use of N-3 polyunsaturated fatty acids and if the effects live up to the marketed claims or if they have more undesirable effects.